Literature DB >> 7856748

Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.

A Furuta1, D L Price, C A Pardo, J C Troncoso, Z S Xu, N Taniguchi, L J Martin.   

Abstract

Abnormalities in the cellular regulation and expression of antioxidant enzymes may have a role in mechanisms of central nervous system aging and neurodegeneration. We therefore examined, using isozyme-specific antibodies and immunohistochemistry, the localization of copper, zinc-superoxide dismutase and manganese-superoxide dismutase in the frontal and temporal neocortices and hippocampi of aged controls and individuals with Alzheimer's disease or Down's syndrome. Two different antibodies to copper, zinc-superoxide dismutase and one antibody to manganese-superoxide dismutase were evaluated by immunoblotting of homogenates of human brain before use in immunohistochemistry. The copper, zinc-superoxide dismutase antibodies recognized a single band of proteins at 16 kd. The manganese-superoxide dismutase antibody detected a single band of proteins at 25 kd. Immunohistochemically, copper, zinc-superoxide dismutase and manganese-superoxide dismutase immunoreactivities were localized predominantly to neocortical and hippocampal pyramidal neurons and scarcely seen in glial cells in controls. In Alzheimer's disease and Down's syndrome, the distributions and intensities of these two forms of superoxide dismutase immunoreactivities were different as compared with controls. Copper, zinc-superoxide dismutase was enriched in pyramidal neurons undergoing degeneration, whereas manganese-superoxide dismutase was more enriched in reactive astrocytes than in neurons. In senile plaques, copper, zinc-superoxide dismutase-positive globular structures were surrounded by astrocytes highly enriched in manganese-superoxide dismutase. By double label immunohistochemistry, some pyramidal neurons coexpressed superoxide dismutases and tau, and a few copper, zinc-superoxide dismutase-positive structures in senile plaques colocalized with tau. Amyloid cores, diffuse plaques, and microglia scarcely showed colocalization with superoxide dismutase-positive structures. The observed changes in the cellular localization of superoxide dismutases in neocortex and hippocampus in cases of Alzheimer's disease and Down's syndrome support a role for oxidative injury in neuronal degeneration and senile plaque formation. The differential localization of copper, zinc-superoxide dismutase and manganese-superoxide dismutase in cerebral sites of degeneration suggests that cellular responses to oxidative stress is antioxidant enzyme specific and cell type specific and that these two forms of superoxide dismutase may have different functions in antioxidant mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7856748      PMCID: PMC1869844     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

Review 1.  Role of superoxide dismutase in cancer: a review.

Authors:  L W Oberley; G R Buettner
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

2.  Reactivity of a monoclonal antibody to manganese superoxide dismutase with human ovarian carcinoma.

Authors:  M Ishikawa; Y Yaginuma; H Hayashi; T Shimizu; Y Endo; N Taniguchi
Journal:  Cancer Res       Date:  1990-04-15       Impact factor: 12.701

3.  Localization of copper-zinc superoxide dismutase mRNA in human hippocampus by in situ hybridization.

Authors:  I Ceballos; F Javoy-Agid; E C Hirsch; S Dumas; P P Kamoun; P M Sinet; Y Agid
Journal:  Neurosci Lett       Date:  1989-10-23       Impact factor: 3.046

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  Distribution of manganese-dependent superoxide dismutase in the human brain.

Authors:  P Zhang; P Anglade; E C Hirsch; F Javoy-Agid; Y Agid
Journal:  Neuroscience       Date:  1994-07       Impact factor: 3.590

7.  Induction of mitochondrial manganese superoxide dismutase by interleukin 1.

Authors:  A Masuda; D L Longo; Y Kobayashi; E Appella; J J Oppenheim; K Matsushima
Journal:  FASEB J       Date:  1988-12       Impact factor: 5.191

8.  Production of tumor necrosis factor-alpha by microglia and astrocytes in culture.

Authors:  M Sawada; N Kondo; A Suzumura; T Marunouchi
Journal:  Brain Res       Date:  1989-07-10       Impact factor: 3.252

9.  Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation.

Authors:  F P Zemlan; O J Thienhaus; H B Bosmann
Journal:  Brain Res       Date:  1989-01-02       Impact factor: 3.252

10.  Expression of the histocompatibility glycoprotein HLA-DR in neurological disease.

Authors:  P L McGeer; S Itagaki; E G McGeer
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

View more
  24 in total

1.  Do nonsteroidal anti-inflammatory drugs have a protective effect against dementia?

Authors:  F L Van Muiswinkel; P Eikelenboom
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

2.  Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide.

Authors:  M A Pappolla; M Sos; R A Omar; R J Bick; D L Hickson-Bick; R J Reiter; S Efthimiopoulos; N K Robakis
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

3.  Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4.

Authors:  K S Montine; S J Olson; V Amarnath; W O Whetsell; D G Graham; T J Montine
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 4.  Glycation vs. glycosylation: a tale of two different chemistries and biology in Alzheimer's disease.

Authors:  Naoyuki Taniguchi; Motoko Takahashi; Yasuhiko Kizuka; Shinobu Kitazume; Vladimir V Shuvaev; Tomomi Ookawara; Akiko Furuta
Journal:  Glycoconj J       Date:  2016-06-21       Impact factor: 2.916

5.  Molecular indices of neuronal and glial plasticity in the hippocampal formation in a rodent model of age-induced spatial learning impairment.

Authors:  K Sugaya; M Chouinard; R Greene; M Robbins; D Personett; C Kent; M Gallagher; M McKinney
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

6.  Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice.

Authors:  I Ferrer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

7.  The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease.

Authors:  M Y Aksenov; H M Tucker; P Nair; M V Aksenova; D A Butterfield; S Estus; W R Markesbery
Journal:  J Mol Neurosci       Date:  1998-10       Impact factor: 3.444

8.  DNA base-excision repair enzyme apurinic/apyrimidinic endonuclease/redox factor-1 is increased and competent in the brain and spinal cord of individuals with amyotrophic lateral sclerosis.

Authors:  Arif Y Shaikh; Lee J Martin
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

9.  Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism.

Authors:  N Y Calingasan; L C Park; L L Calo; R R Trifiletti; S E Gandy; G E Gibson
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

10.  Calorie restriction attenuates astrogliosis but not amyloid plaque load in aged rhesus macaques: a preliminary quantitative imaging study.

Authors:  Aadhavi Sridharan; Mariana Pehar; M Shahriar Salamat; Thomas D Pugh; Barbara B Bendlin; Auriel A Willette; Rozalyn M Anderson; Joseph W Kemnitz; Ricki J Colman; Richard H Weindruch; Luigi Puglielli; Sterling C Johnson
Journal:  Brain Res       Date:  2013-03-07       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.